Navigation Links
Study Finds That Migraine Drug Can Ease The Severest Of Facial Pain

A new study in Japan has found migraine medication sumatriptan, known by the brand names Imitrex or Imigran, can provide relief for pain// due to trigeminal neuralgia up to eight hours.

Now researchers have found that a migraine medication could provide relief for people who suffer from, trigeminal neuralgia. Researchers had injected the drug and found it produced rapid and significant pain relief without serious adverse reactions.

Pain experienced with trigeminal neuralgia that affects the nerves in the face, sometimes known as tic douloureux, comes in lightning-like stabs that radiate from the angle of the jaw to the front of the face. The shocks are momentary but can repeat for several seconds. Paroxysms may last for hours, and then subside for long periods. This pain is often considered as one of the severest pains. Compression of the root of the trigeminal nerves by an artery is thought to cause trigeminal neuralgia.

Dr Akifumi Kanai and colleagues from Kitasato University School of Medicine explained this in the journal of Headache. The team led by Dr Kanai's examined the possible effectiveness of a subcutaneous injection of sumatriptan compared with saline in the treatment of trigeminal neuralgia in 24 patients. According to investigators, it was found to significantly decrease pain scores on a 0-10 scale from 8.3 to 2.4, according to the investigators. Pain scores did not change with placebo injection. Twenty patients described their pain as moderately or slightly better after sumatriptan treatment as compared with only one patient after being injected with saline injection. The analgesic effect of sumatriptan lasted for 1 to 20 hours, averaging 7.9 hours overall.

Dr Julio Pascual of University Hospital in Salamanca, Spain, in his editorial explained that the rapid onset of relief is plus, but subcutaneous injections that should be given at least twice a day would be a drawback. He went to suggest that sumatrip tan might be ideal as short-term treatment until oral drugs begin to work, or as rescue treatment. He also stated that he would like to see if other "triptans" that can be delivered orally or by nasal spray would work for trigeminal neuralgia.


Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:

(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
(Date:6/24/2016)... ... 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The ... members that have been wounded in battle and their families. Venture Construction Group is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: